Celtic Biotech
  • Home
  • CB-24
  • Our Pipeline
  • The Team
  • FAQ
  • More
    • Home
    • CB-24
    • Our Pipeline
    • The Team
    • FAQ
Celtic Biotech
  • Home
  • CB-24
  • Our Pipeline
  • The Team
  • FAQ

Video

Visualisation of CB24 Mechanism of Action

Celtic Biotech's leading compound in early trials has a novel mechanism of action 

which has a particular affinity for targeting cancerous cells and by-passing healthy ones

Mechanism of Action

Copyright © 2024 Celtic Biotech - All Rights Reserved.

This website uses cookies.

We would like to use cookies to analyse website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept